Easy-to-understand Financial Insights
that build Wealth.

Biocon's Bengaluru Facility Gets Four Observations from US FDA; No Business Impact Expected

  • The US Food and Drug Administration (US FDA) conducted a surveillance inspection of Biocon's API facility in Bengaluru from 23rd to 27th September 2024.
  • Four observations were cited d…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

Learn More